Consortium Member of the Month

Our consortium member of the month for the month of July goes to Assistant Director Chris Manring from Ohio State University!

Chris Manring, MBA

We are proud to highlight Chris Manring, MBA, who has been an integral member to the Ohio State University Comprehensive Cancer Center (OSUCCC)  Leukemia and Hematologic Malignancy Program and bringing OSU into the MPN-RC. He is currently the Assistant Director for the OSUCCC Hematology Tissue Bank, which has led to his critical role in implementing the MPN-RC 106 tissue bank at OSU. His staff members wanted to specifically highlight that Chris is a dedicated and compassionate assistant director who leads our team with genuine passion and a strong commitment to the fight against blood cancers. He consistently demonstrates a proactive approach, eagerly taking on new initiatives and supporting providers in their efforts—understanding that these contributions have a lasting impact on the lives of countless patients. In addition to his professional excellence, Chris is a devoted family man, friend, proud husband, and father to two remarkable children.

Nominated by: Dr. Andrew Srisuwananukorn

Chris, thank you so much for all of the phenomenal work you have done for the consortium.

Keep up the great work!

Title: Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A

Author(s): Charlotte K Brierley, Bon Ham Yip, Giulia Orlando, Jeremy Wen, Sean Wen, Harsh Goyal, Max Levine, G Maria Jakobsdottir, Avraam Tapinos, Alex J Cornish, Antonio Rodriguez-Romera, Alba Rodriguez-Meira, Matthew Bashton, Angela Hamblin, Sally Ann Clark, Joseph C Hamley, Olivia Fox, Madalina Giurgiu, Jennifer O’Sullivan, Lauren Murphy, Assunta Adamo, Aude Anais Olijnik, Anitria Cotton, Emily Hendrix, Shilpa Narina, Shondra M Pruett-Miller, Amir Enshaei, Claire Harrison, Mark Drummond, Steven Knapper, Ayalew Tefferi, Iléana Antony-Debré, James Davies, Anton G Henssen, Supat Thonjuea, David C Wedge, Stefan N Constantinescu, Elli Papaemmanuil, Bethan Psaila, John D Crispino, Adam J Mead

MPN-RC Monthly Publication

MPN-RC Updates: ASH Conference 2024

  • ASH Conference 2024

    (Left to Right: Susan Geyer, Carolyn Mead-Harvey, and Dr. Amylou Dueck) The Mayo Clinic group from the MPN Research Consortium attended the American Society of Hematology 2024 Conference in San Diego, California from December 7th - 10th.

  • ASH Conference 2024

    Dr. Shivani Handa presents her ASH abstract “243 TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms”. View the abstract here!

  • ASH Conference 2024

    Dr. Anna Rita Migliaccio asking after the talk at the plenary session on megakaryocytes in the elderly whether the GATA1low megakaryocytes which are enriched in the elderly represent an enrichment in the immune-megakaryocte subpopulations. 

  • Bridget Kelly Marcellino, MD,PhD

    873 Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells

    Full ASH Abstract

  • Shivani Handa, MD

    243 TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

    Full ASH Abstract